The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

Varanasi: An awareness programme was organised by Sathiya Kendra of the Institute of Medical Sciences (IMS), Banaras Hindu ...

Merck MRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings ...

HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...

Merck maintained its 2025 full-year revenue guidance of $64.1 billion to $65.6 billion, representing 1% to 3% growth excluding foreign exchange impacts. EPS guidance was adjusted to $8.82 to $8.97, ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

The US has made some progress in the fight against some cancers, but prevention for others isn’t increasing. According to a ...

“Unfortunately, Alabama is significantly higher in both cervical cancer incidence and mortality rates when compared to the U.S. Fortunately, HPV vaccination can eliminate the vast majority of cervical ...

For 2025, Merck said it still expects sales of $64.1 billion to $65.6 billion, but it lowered its adjusted earnings per share ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...